Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An oncogene is a mutated or aberrantly expressed gene that causes or contributes to the transformation of a normal cell into a cancer cell by driving uncontrolled proliferation and/or evasion of cell death. Oncogenes originate from normal proto-oncogenes, which are essential for regulating normal cell division and survival; once mutated or over-expressed, they act like a stuck accelerator in cell growth, leading to cancer. Oncogenes encompass many distinct molecules—such as growth factors, receptors, signaling molecules, and transcription factors—and many cancer therapies target their protein products, but the term itself does not designate a specific molecular target. For structured data and drug development, it is necessary to specify the individual oncogene involved (e.g., BCR-ABL, MYC, EGFR), not the generic "oncogene."
None universally; specific mechanisms target individual oncogene proteins (e.g., kinase inhibition for BCR-ABL)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oncogene (None).